16 research outputs found
Prevention of catheter lumen occlusion with rT-PA versus heparin (Pre-CLOT): study protocol of a randomized trial [ISRCTN35253449]
BACKGROUND: Many patients with end-stage renal disease use a central venous catheter for hemodialysis access. A large majority of these catheters malfunction within one year of insertion, with up to two-thirds due to thrombosis. The optimal solution for locking the catheter between hemodialysis sessions, to decrease the risk of thrombosis and catheter malfunction, is unknown. The Prevention of Catheter Lumen Occlusion with rt-PA versus Heparin (PreCLOT) study will determine if use of weekly rt-PA, compared to regular heparin, as a catheter locking solution, will decrease the risk of catheter malfunction. METHODS/DESIGN: The study population will consist of patients requiring chronic hemodialysis thrice weekly who are dialyzed with a newly inserted permanent dual-lumen central venous catheter. Patients randomized to the treatment arm will receive rt-PA 1 mg per lumen once per week, with heparin 5,000 units per ml as a catheter locking solution for the remaining two sessions. Patients randomized to the control arm will receive heparin 5,000 units per ml as a catheter locking solution after each dialysis session. The study treatment period will be six months, with 340 patients to be recruited from 14 sites across Canada. The primary outcome will be catheter malfunction, based on mean blood flow parameters while on hemodialysis, with a secondary outcome of catheter-related bacteremia. A cost-effectiveness analysis will be undertaken to assess the cost of maintaining a catheter using rt-PA as a locking solution, compared to the use of heparin. DISCUSSION: Results from this study will determine if use of weekly rt-PA, compared to heparin, will decrease catheter malfunction, as well as assess the cost-effectiveness of these locking solutions
Robust estimation of bacterial cell count from optical density
Optical density (OD) is widely used to estimate the density of cells in liquid culture, but cannot be compared between instruments without a standardized calibration protocol and is challenging to relate to actual cell count. We address this with an interlaboratory study comparing three simple, low-cost, and highly accessible OD calibration protocols across 244 laboratories, applied to eight strains of constitutive GFP-expressing E. coli. Based on our results, we recommend calibrating OD to estimated cell count using serial dilution of silica microspheres, which produces highly precise calibration (95.5% of residuals <1.2-fold), is easily assessed for quality control, also assesses instrument effective linear range, and can be combined with fluorescence calibration to obtain units of Molecules of Equivalent Fluorescein (MEFL) per cell, allowing direct comparison and data fusion with flow cytometry measurements: in our study, fluorescence per cell measurements showed only a 1.07-fold mean difference between plate reader and flow cytometry data
Multilocus ISSR Markers Reveal Two Major Genetic Groups in Spanish and South African Populations of the Grapevine Fungal Pathogen Cadophora luteo-olivacea
Cadophora luteo-olivacea is a lesser-known fungal trunk pathogen of grapevine which has been recently isolated from vines showing decline symptoms in grape growing regions worldwide. In this study, 80 C. luteo-olivacea isolates (65 from Spain and 15 from South Africa) were studied. Inter-simple-sequence repeat-polymerase chain reaction (ISSR-PCR) generated 55 polymorphic loci from four ISSR primers selected from an initial screen of 13 ISSR primers. The ISSR markers revealed 40 multilocus genotypes (MLGs) in the global population. Minimum spanning network analysis showed that the MLGs from South Africa clustered around the most frequent genotype, while the genotypes from Spain were distributed all across the network. Principal component analysis and dendrograms based on genetic distance and bootstrapping identified two highly differentiated genetic clusters in the Spanish and South African C. luteo-olivacea populations, with no intermediate genotypes between these clusters. Movement within the Spanish provinces may have occurred repeatedly given the frequent retrieval of the same genotype in distant locations. The results obtained in this study provide new insights into the population genetic structure of C. luteo-olivacea in Spain and highlights the need to produce healthy and quality planting material in grapevine nurseries to avoid the spread of this fungus throughout different grape growing regions
A study of teachers' conceptions and teaching strategies in relation to students' alternative ideas about force and motion
published_or_final_versionEducationMasterMaster of Educatio
Synthesis and Characterization of Bromophenol Glucuronide and Sulfate Conjugates for Their Direct LC-MS/MS Quantification in Human Urine as Potential Exposure Markers for Polybrominated Diphenyl Ethers
Bromophenol glucuronide and sulfate conjugates have been
reported
to be products of mammalian metabolism of polybrominated diphenyl
ethers (PBDEs), a group of additive flame-retardants found ubiquitously
in the environment. In order to explore their occurrence in human
urine, four water-soluble bromophenol conjugates, namely, 2,4-dibromophenyl
glucuronide, 2,4,6-tribromophenyl glucuronide, 2,4-dibromophenyl sulfate,
and 2,4,6-tribromophenyl sulfate, were synthesized, purified, and
characterized. An analytical protocol using solid-phase extraction
and ion-paired liquid chromatography–electrospray tandem mass
spectrometry (LC-ESI-MS/MS) quantification has been developed for
the direct and simultaneous determination of these glucuronide and
sulfate conjugates in human urine samples. The limit of detections
for all analytes were below 13 pg mL<sup>–1</sup>, with 73–101%
analyte recovery and 7.2–8.6% repeatability. The method was
applied to analyze 20 human urine samples collected randomly from
voluntary donors in Hong Kong SAR, China. All the samples were found
to contain one or more of the bromophenol conjugates, with concentration
ranging from 0.13–2.45 μg g<sup>–1</sup> creatinine.
To the best of our knowledge, this is the first analytical protocol
for the direct and simultaneous monitoring of these potential phase
II metabolites of PBDEs in human urine. Our results have also suggested
the potential of these bromophenol conjugates in human urine to be
convenient molecular markers for the quantification of population
exposure to PBDEs